<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31696295</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature.</ArticleTitle><Pagination><StartPage>607</StartPage><EndPage>615</EndPage><MedlinePgn>607-615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-019-09615-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The importance of elucidating the relationships between pain, mood and quality of life (QoL) amongst people with amyotrophic lateral sclerosis/motor neuron disease is evident to clinicians, yet the literature is limited and inconsistent. We explored the relationships between pain, depression, anxiety and QoL to reconcile the previous contrasting findings and inform future research and clinical practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patient-reported outcomes were obtained as part of the Trajectories of Outcomes in Neurological Conditions study. Mood and QoL scales underwent Rasch analysis. Correlation coefficients examined the strength of association between variables of interest. A bivariate regression model was developed to examine the effects of pain, depression and anxiety on joint psychological and physical QoL domains.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 636 people with ALS, 69% reported pain, of these most had mild pain. Seven percent (7%) of participants exceeded published cutoffs for probable depression and 14% had probable anxiety. Pain, depression and anxiety all influence quality of life; depression has a significant effect on both physical and psychological domains of QoL, whereas pain affects physical QoL and anxiety psychological QoL.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results show the importance of expressing quality of life in a conceptually appropriate way, as failing to take account of the multidimensional nature of QoL can result in important nuances being overlooked. Clinicians must be aware that pain, depression and anxiety all worsen QoL across their ranges, and not just when pain is severe or when anxiety or depression reach case level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edge</LastName><ForeName>Rhiannon</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5349-783X</Identifier><AffiliationInfo><Affiliation>Lancaster Medical School, Lancaster University, B38 Furness Building, Bailrigg, Lancaster, UK, LA1 4YW. r.edge@lancaster.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Walton Centre NHS Trust, Lower Lane, Liverpool, L9 7LJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tennant</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emeritus Professor, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diggle</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Lancaster Medical School, Lancaster University, B38 Furness Building, Bailrigg, Lancaster, UK, LA1 4YW.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Carolyn A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Walton Centre NHS Trust, Lower Lane, Liverpool, L9 7LJ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, L69 3BX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TONiC study group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ALCHALABI-TALBOT/APR14/926-794</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>YOUNG/JAN15/929-794</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Neurol. 2020 Jan 28;:</RefSource><PMID Version="1">31989281</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Motor neuron disease (MND)</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">TONiC study</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Timothy L</ForeName><Initials>TL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dick</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Talbot</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burke</LastName><ForeName>Georgina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Majeed</LastName><ForeName>Tahir</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ealing</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDermott</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Ashwin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Carolyn A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walsh</LastName><ForeName>Jannette</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hanemann</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harrower</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31696295</ArticleId><ArticleId IdType="pmc">PMC7035222</ArticleId><ArticleId IdType="doi">10.1007/s00415-019-09615-3</ArticleId><ArticleId IdType="pii">10.1007/s00415-019-09615-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JM, van den Berg LH, Schroder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14(1):107. doi: 10.1186/s12955-016-0507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-016-0507-6</ArticleId><ArticleId IdType="pmc">PMC4955215</ArticleId><ArticleId IdType="pubmed">27439463</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Atkins L, Leigh PN. Correlates of Quality of Life in people with motor neuron disease (MND) Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(3):123&#x2013;129. doi: 10.1080/146608202760834120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608202760834120</ArticleId><ArticleId IdType="pubmed">12495573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144&#x2013;157. doi: 10.1016/s1474-4422(16)30358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(16)30358-1</ArticleId><ArticleId IdType="pubmed">27964824</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F, Lunetta C, Banfi P, Rossi G, Fossati F, Marconi A, Castelnuovo G, Corbo M, Molinari E. Pain in amyotrophic lateral sclerosis: a psychological perspective. Neurol Sci. 2012;33(5):1193&#x2013;1196. doi: 10.1007/s10072-011-0888-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0888-6</ArticleId><ArticleId IdType="pubmed">22183268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28(2):115&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812727</ArticleId><ArticleId IdType="pubmed">24125561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122&#x2013;123. doi: 10.1212/01.WNL.0000042781.22278.0A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000042781.22278.0A</ArticleId><ArticleId IdType="pubmed">12525733</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe MP, Firth L, O&#x2019;Connor E. A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings. 2009;16(4):355&#x2013;362. doi: 10.1007/s10880-009-9168-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10880-009-9168-5</ArticleId><ArticleId IdType="pubmed">19639395</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schroder R, Heuss D, Vielhaber S, Tackenberg B, Mylius V, Reese JP, Kiefer R, Schrank B, Oertel WH, Dodel R. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257(9):1473&#x2013;1481. doi: 10.1007/s00415-010-5549-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5549-9</ArticleId><ArticleId IdType="pubmed">20383521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D, Pauli S, Altintas E, Singer U, Merk T, Uttner I, Birbaumer N, Ludolph AC. Emotional adjustment in amyotrophic lateral sclerosis (ALS) J Neurol. 2012;259(2):334&#x2013;341. doi: 10.1007/s00415-011-6191-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6191-x</ArticleId><ArticleId IdType="pubmed">21808983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons C, Thornton E, Ealing J, Shaw P, Talbot K, Tennant A, Young C. The role of fatigue and psychosocial phenomena in the determination of quality of life for patients with motor neurone disease. Amyotrophic Lateral Sclerosis. 2013;14(7&#x2013;8):537&#x2013;545. doi: 10.3109/21678421.2013.799700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.799700</ArticleId><ArticleId IdType="pubmed">23725553</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Pioro EP. Depression in ALS in a large self-reporting cohort. Neurology. 2016;86(11):1031&#x2013;1038. doi: 10.1212/WNL.0000000000002465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002465</ArticleId><ArticleId IdType="pubmed">26888995</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson Larsson B, Ozanne AG, Nordin K, Nygren I. A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136(6):631&#x2013;638. doi: 10.1111/ane.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12774</ArticleId><ArticleId IdType="pubmed">28523721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52(7):1434&#x2013;1440. doi: 10.1212/WNL.52.7.1434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.7.1434</ArticleId><ArticleId IdType="pubmed">10227631</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S, Hickey A, O&#x2019;Boyle C, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res. 2001;10(2):149&#x2013;158. doi: 10.1023/A:1016704906100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016704906100</ArticleId><ArticleId IdType="pubmed">11642685</ArticleId></ArticleIdList></Reference><Reference><Citation>Peric&#x2019; S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V, Marjanovic L, Lavrnic D. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg. 2010;110(1):71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">20514929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramonti F, Bongioanni P, Di Bernardo C, Davitti S, Rossi B. Quality of life of patients with amyotrophic lateral sclerosis. Psychol Health Med. 2012;17(5):621&#x2013;628. doi: 10.1080/13548506.2011.651149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2011.651149</ArticleId><ArticleId IdType="pubmed">22313252</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S, K&#xf6;rner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S. Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol. 2015;15:84. doi: 10.1186/s12883-015-0340-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-015-0340-2</ArticleId><ArticleId IdType="pmc">PMC4493831</ArticleId><ArticleId IdType="pubmed">25982050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269&#x2013;273. doi: 10.1016/j.jns.2016.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.09.034</ArticleId><ArticleId IdType="pubmed">27772773</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignola A, Guzzo A, Calvo A, Moglia C, Pessia A, Cavallo E, Cammarosano S, Giacone S, Ghiglione P, Chi&#xf2; A. Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol. 2008;15(11):1231. doi: 10.1111/j.1468-1331.2008.02303.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02303.x</ArticleId><ArticleId IdType="pubmed">18803649</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe MP, Firth L, O&#x2019;Connor E. Mood and quality of life among people with progressive neurological illnesses. Int J Clin Health Psychol. 2009;9(1):21&#x2013;35.</Citation></Reference><Reference><Citation>O&#x2019;Doherty LJ, Hickey A, Hardiman O. Measuring life quality, physical function and psychological well-being in neurological illness. Amyotroph Lateral Scler. 2010;11(5):461&#x2013;468. doi: 10.3109/17482960903552488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903552488</ArticleId><ArticleId IdType="pubmed">20192883</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan B, Rose N, Griffiths J, Young C, Trajectories of Outcome in Neurological Conditions (TONiC) Study Group Professionals&#x2019; opinions on the physical factors affecting quality of life in multiple sclerosis and motor neurone disease: pilot work from the Trajectories of Outcomes in Neurological Conditions study. J Neurol. 2013;260(S1):26.</Citation></Reference><Reference><Citation>The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551&#x2013;558. doi: 10.1017/S0033291798006667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291798006667</ArticleId><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci. 1994;124(Suppl):96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schl&#xfc;ter DK, Tennant A, Mills R, Diggle PJ, Young CA. Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(7&#x2013;8):591&#x2013;598. doi: 10.1080/21678421.2018.1508477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1508477</ArticleId><ArticleId IdType="pubmed">30398087</ArticleId></ArticleIdList></Reference><Reference><Citation>Skevington SM, Lotfy M, O&#x2019;Connell KA. The World Health Organization&#x2019;s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299&#x2013;310. doi: 10.1023/B:QURE.0000018486.91360.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:QURE.0000018486.91360.00</ArticleId><ArticleId IdType="pubmed">15085902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, Talbot K, Tennant A, Young CA. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82&#x2013;90. doi: 10.1186/1477-7525-9-82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-9-82</ArticleId><ArticleId IdType="pmc">PMC3192662</ArticleId><ArticleId IdType="pubmed">21955749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960.</Citation></Reference><Reference><Citation>da Rocha NS, Chachamovich E, de Almeida Fleck MP, Tennant A. An introduction to Rasch analysis for psychiatric practice and research. J Psychiatr Res. 2013;47(2):141&#x2013;148. doi: 10.1016/j.jpsychires.2012.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2012.09.014</ArticleId><ArticleId IdType="pubmed">23069651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A, Reise S, Haviland M. Evaluating bi-factor models: calculating and interpreting statistical indices. Psychol Methods. 2016;21:137&#x2013;150. doi: 10.1037/met0000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/met0000045</ArticleId><ArticleId IdType="pubmed">26523435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallant JF, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS) Br J Clin Psychol. 2007;46:1&#x2013;18. doi: 10.1348/014466506X96931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/014466506X96931</ArticleId><ArticleId IdType="pubmed">17472198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum. 2007;57(8):1358&#x2013;1362. doi: 10.1002/art.23108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23108</ArticleId><ArticleId IdType="pubmed">18050173</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, Burke G, Pinto A, Dick D, Talbot K, Harrower T, Walsh J, Chandran S, Hanemann CO, Mills R, Tennant A. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019 doi: 10.1080/21678421.2019.1615951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1615951</ArticleId><ArticleId IdType="pubmed">31116037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rencher AC. Methods of multivariate analysis. 2. New Jersey: Wiley; 2003.</Citation></Reference><Reference><Citation>Pillai KCS. Some new test criteria in multivariate analysis. Ann Math Stat. 1955;26(1):117&#x2013;121. doi: 10.1214/aoms/1177728599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aoms/1177728599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida N, Hongo S, Kumano A, Hatta H, Zakoji N, Hirutani M, Yamamoto Y, Aono H, Tuigi M, Suzuki R, Hanamitsu H, Wakasugi E, Takahashi M, Yamatani A. Relationship between pain and functional status in patients with amyotrophic lateral sclerosis: a multicenter cross-sectional study. J Palliat Med. 2018;21(5):588&#x2013;591. doi: 10.1089/jpm.2017.0503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2017.0503</ArticleId><ArticleId IdType="pubmed">29319397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, Papurello D, Calvo A. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012;19(4):551&#x2013;555. doi: 10.1111/j.1468-1331.2011.03540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03540.x</ArticleId><ArticleId IdType="pubmed">21972798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch F, Skudlarek A, Berndt J, Kornhuber ME. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5(3):e00296. doi: 10.1002/brb3.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.296</ArticleId><ArticleId IdType="pmc">PMC4309879</ArticleId><ArticleId IdType="pubmed">25642388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace VC, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7&#x2013;8):520&#x2013;527. doi: 10.3109/21678421.2014.951944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.951944</ArticleId><ArticleId IdType="pubmed">25204842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P. Reassessing received wisdom in ALS&#x2014;pain is common when studied systematically. Eur J Neurol. 2012;19(4):531&#x2013;532. doi: 10.1111/j.1468-1331.2011.03541.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03541.x</ArticleId><ArticleId IdType="pubmed">21972839</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(suppl 1):i1&#x2013;i57. doi: 10.1093/ageing/afs200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afs200</ArticleId><ArticleId IdType="pubmed">23420266</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer MJ, Struys MMRF, Versteegen GJ. Pain-related catastrophizing in pain patients and people with pain in the general population. Eur J Pain. 2012;16(7):1044&#x2013;1052. doi: 10.1002/j.1532-2149.2012.00136.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1532-2149.2012.00136.x</ArticleId><ArticleId IdType="pubmed">22416040</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis. 1981;34(12):585&#x2013;597. doi: 10.1016/0021-9681(81)90058-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(81)90058-8</ArticleId><ArticleId IdType="pubmed">7309824</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(2):109&#x2013;112. doi: 10.3109/17482968.2010.536839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.536839</ArticleId><ArticleId IdType="pmc">PMC3155886</ArticleId><ArticleId IdType="pubmed">21091399</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC. Practice Parameter update: the care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227&#x2013;1233. doi: 10.1212/WNL.0b013e3181bc01a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc01a4</ArticleId><ArticleId IdType="pmc">PMC2764728</ArticleId><ArticleId IdType="pubmed">19822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes SC, Strosahl KD, Wilson KG (1999) Acceptance and commitment therapy: an experiential approach to behavior change. Guilford Press, New York. https://psycnet.apa.org/record/1999-04037-000</Citation></Reference><Reference><Citation>Pagnini F, Phillips D, Bosma CM, Reece A, Langer E. Mindfulness, physical impairment and psychological well-being in people with amyotrophic lateral sclerosis. Psychol Health. 2015;30(5):503&#x2013;517. doi: 10.1080/08870446.2014.982652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08870446.2014.982652</ArticleId><ArticleId IdType="pubmed">25361013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>